Inventor
GARY K. LEE
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes32%
C07KPeptides26%
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
PatentTitleYear
12,516,098Chimeric antigen receptor mediated cell targeting202611,661,611Genetic modification of cytokine inducible SH2-containing protein (CISH) gene202311,512,287Targeted disruption of T cell and/or HLA receptors202211,452,782Liver-specific constructs factor VIII expression cassettes and methods of use thereof202211,352,631Targeted disruption of the T cell receptor202211,285,175Targeted disruption of the MHC cell receptor2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2026Patents assigned to SANGAMO THERAPEUTICS INC (6)· patent assignee history
2022Patents assigned to SANGAMO BIOSCIENCES INC (1)· patent assignee history
2022–2026Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SANGAMO THERAPEUTICS INC | 6 | 2022–2026 |
| SANGAMO BIOSCIENCES INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2026 |